GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $30,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $30,000 | -3.2% | 700 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $31,000 | +14.8% | 700 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $27,000 | -38.6% | 700 | -36.4% | 0.00% | 0.0% |
Q2 2021 | $44,000 | +12.8% | 1,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $39,000 | -2.5% | 1,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $40,000 | -2.4% | 1,100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $41,000 | -8.9% | 1,100 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $45,000 | -78.9% | 1,100 | -80.4% | 0.00% | -77.8% |
Q1 2020 | $213,000 | +0.9% | 5,600 | +24.4% | 0.01% | +12.5% |
Q4 2019 | $211,000 | -45.1% | 4,500 | -50.0% | 0.01% | -50.0% |
Q3 2019 | $384,000 | +6.7% | 9,000 | 0.0% | 0.02% | +6.7% |
Q2 2019 | $360,000 | -4.3% | 9,000 | 0.0% | 0.02% | -6.2% |
Q1 2019 | $376,000 | -21.3% | 9,000 | -28.0% | 0.02% | -20.0% |
Q4 2018 | $478,000 | -5.0% | 12,500 | 0.0% | 0.02% | +11.1% |
Q3 2018 | $503,000 | -22.0% | 12,500 | -21.9% | 0.02% | -25.0% |
Q2 2018 | $645,000 | +3.2% | 16,000 | 0.0% | 0.02% | +4.3% |
Q1 2018 | $625,000 | -2.0% | 16,000 | -11.1% | 0.02% | +109.1% |
Q4 2017 | $638,000 | +74.8% | 18,000 | +100.0% | 0.01% | -15.4% |
Q3 2017 | $365,000 | -6.9% | 9,000 | -0.9% | 0.01% | -7.1% |
Q2 2017 | $392,000 | +2.6% | 9,083 | 0.0% | 0.01% | +7.7% |
Q1 2017 | $382,000 | -83.5% | 9,083 | -84.9% | 0.01% | -80.9% |
Q4 2016 | $2,314,000 | +5.0% | 60,083 | +17.6% | 0.07% | +6.2% |
Q3 2016 | $2,204,000 | -4.2% | 51,083 | -3.8% | 0.06% | -4.5% |
Q2 2016 | $2,301,000 | +4.7% | 53,083 | -2.1% | 0.07% | 0.0% |
Q1 2016 | $2,197,000 | +625.1% | 54,197 | +624.4% | 0.07% | +570.0% |
Q4 2015 | $303,000 | +0.3% | 7,482 | -5.1% | 0.01% | -16.7% |
Q3 2015 | $302,000 | +44.5% | 7,882 | +57.3% | 0.01% | +50.0% |
Q2 2015 | $209,000 | -3.7% | 5,010 | +6.9% | 0.01% | 0.0% |
Q1 2015 | $217,000 | +35.6% | 4,685 | +56.2% | 0.01% | +14.3% |
Q4 2013 | $160,000 | – | 3,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |